Invitation to DMEA - Warming Up Pitch Session
The XPAND-program of the Hungarian Innovation Agency NIÜ offers
Hungarian start-ups and SMEs the opportunity to participate
in Europe’s leading conference and exhibition
for digital health in Berlin.
On the conference’s eve a networking event will take place
at the Hungarian Embassy, featuring the National Innovation Agency,
innovative Hungarian MedTech companies, and potential
cooperation partners participating in the fair.
Invitation to DMEA - Warming Up Pitch Session
The XPAND-program of the Hungarian Innovation Agency NIÜ offers
Hungarian start-ups and SMEs the opportunity to participate
in Europe’s leading conference and exhibition
for digital health in Berlin.
On the conference’s eve a networking event will take place
at the Hungarian Embassy, featuring the National Innovation Agency,
innovative Hungarian MedTech companies, and potential
cooperation partners participating in the fair.
We are very pleased to invite and welcome you to this event!
Date:
7th April 2025
Time: 17.00
Location:
Hungarian Embassy, Unter den Linden 76, 10117 Berlin
Date:
7th April 2025
Time: 17.00
Location:
Hungarian Embassy, Unter den Linden 76, 10117 Berlin
ECG247
ECG247 is an easy-to-use, 24/7 heart monitoring sensor combined with a mobile app that can detect heart rhythm disorders such as atrial fibrillation or arrhythmias early.
- Easy to use, wireless sensor for remote monitoring
- Compact, waterproof, and reusable
- Automatic interpretation and immediate results
- Transmission of information to the general practitioner and/or cardiologist
- Continuous recording with the associated app, 24 hours a day, 7 days a week
HEALSKILL
HealSkill is an innovative healthtech startup developing a smart health monitoring and risk prediction platform. Our AI-driven application helps users track their health data, assess potential risks, and receive personalized recommendations for a healthier lifestyle. By combining real-world data with advanced analytics, we empower individuals to take proactive steps in managing their well-being. Beyond personal use, our solution offers business applications in private healthcare, insurance, and corporate wellness programs, enabling providers to enhance preventive care, reduce costs, and improve overall health outcomes. Our mission is to make health insights accessible and actionable for individuals and businesses alike.
HEALSKILL
EBI.BIO
The European Biomedical Institute (EBI) is a leading partner in medical device testing, ensuring that companies meet strict international regulatory standards. With a strong focus on biocompatibility, EBI offers a full range of testing services for medical devices, adhering to ISO 10993 standards.
Key benefits of working with EBI include:
- ISO 17025 & GLP Certified: EBI guarantees accurate, reliable test results.
- Comprehensive Biocompatibility Testing: Covering cytotoxicity, genotoxicity, hemocompatibility, and more.
- Regulatory Expertise: Support for navigating FDA, EU, and global regulations.
- Time Performance: With over 96.1% of tests completed well ahead of schedule in 2022, EBI prides itself on delivering results before deadlines.
iPASy Technologies
iPASy Technologies Ltd. is a clinical-study stage startup focused on revolutionizing prostate cancer screening through a proprietary urine-based test. iPASy was founded in 2023 as a spin-off company from University of Pannonia to utilize Professor Guttman’s (co-founder) pioneering expertise of glycomics and deliver demanding solution for men in need. iPASy has a multi-disciplinary group of leading scientists and engineers who partnered with experienced business accelerators and IVD experts to ensure successful ongoing clinical validation in Germany. Market lunch is scheduled in late 2026 in the European Union and then in the United States.
iPASy Technologies
iPASy Technologies Ltd. is a clinical-study stage startup focused on revolutionizing prostate cancer screening through a proprietary urine-based test. iPASy was founded in 2023 as a spin-off company from University of Pannonia to utilize Professor Guttman’s (co-founder) pioneering expertise of glycomics and deliver demanding solution for men in need. iPASy has a multi-disciplinary group of leading scientists and engineers who partnered with experienced business accelerators and IVD experts to ensure successful ongoing clinical validation in Germany. Market lunch is scheduled in late 2026 in the European Union and then in the United States.
Kadasolutions
AI Development, Digital Health Software Prototyping
Ready to revolutionize your industry with a game-changing digital health product? Let us be your guiding force. At Kadasolutions, we’re dedicated to turning your ideas into impactful digital health solutions. From the initial idea phase, through the creation of design wireframes, prototypes, and finally the MVP itself, we’re with you every step of the way. We provide AI consulting to help digital health companies identify and optimize processes and workflows, improving efficiency and driving innovation.
Kinepict
Kinepict – enhancing vascular imaging while reducing radiation exposure and contrast agent use
Cardiovascular diseases and cancer cause 11 million deaths annually in the EU and US, increasing the need for safer and more effective imaging in minimally invasive procedures. X-ray-based visualization of blood vessels is indispensable for these interventions, yet traditional Digital Subtraction Angiography (DSA) has significant drawbacks, including high radiation exposure, contrast-induced kidney damage, and
inadequate visualization of small vessels—limiting optimal treatment for many patients. Kinepict has developed the Kinepict Medical Imaging Tool (KMIT), an FDA-cleared and CE-marked Class 2a medical device. KMIT integrates with GE, Philips, and Siemens systems—ensuring immediate compatibility with over 10,000 imaging units in the EU and USA.
Kinepict
Kinepict – enhancing vascular imaging while reducing radiation exposure and contrast agent use
Cardiovascular diseases and cancer cause 11 million deaths annually in the EU and US, increasing the need for safer and more effective imaging in minimally invasive procedures. X-ray-based visualization of blood vessels is indispensable for these interventions, yet traditional Digital Subtraction Angiography (DSA) has significant drawbacks, including high radiation exposure, contrast-induced kidney damage, and
inadequate visualization of small vessels—limiting optimal treatment for many patients. Kinepict has developed the Kinepict Medical Imaging Tool (KMIT), an FDA-cleared and CE-marked Class 2a medical device. KMIT integrates with GE, Philips, and Siemens systems—ensuring immediate compatibility with over 10,000 imaging units in the EU and USA.
RoLink Biotechnology
RoLink – powering the next generation of biodefense
RoLink Biotechnology is a Hungarian startup founded by two dedicated researcher-doctors on a mission to revolutionize pandemic preparedness. Their disruptive UV-inactivation technology neutralizes viruses at industrial scale while preserving structural integrity, slashing costs by up to 90%. By delivering rapid-response capabilities for R&D, vaccine, and drug development, Already part of a NATO-compatible program, this agile team provides safe, scalable, and cost-effective solutions that are transforming global health security.
OrthoGraph
OrthoGraph offers high-speed, cost-effective building data digitization with a SaaS model for real-time updates, enhancing lifecycle management. It addresses the high cost and complexity of traditional models with fast, accurate survey-to-BIM technology and graphical asset inventory.
Advantages of using OrthoGraph:
- Comprehensive graphic asset inventory with unique identifiers
- Mobile/web access for real-time updates and decision-making
- Accurate, quick building modeling with operational data integration
- Open API for third-party integration
- Cost-effective, scalable SaaS for large portfolios
OrthoGraph
OrthoGraph offers high-speed, cost-effective building data digitization with a SaaS model for real-time updates, enhancing lifecycle management. It addresses the high cost and complexity of traditional models with fast, accurate survey-to-BIM technology and graphical asset inventory.
Advantages of using OrthoGraph:
- Comprehensive graphic asset inventory with unique identifiers
- Mobile/web access for real-time updates and decision-making
- Accurate, quick building modeling with operational data integration
- Open API for third-party integration
- Cost-effective, scalable SaaS for large portfolios